APA (7th ed.) Citation

E, B., MT, L., KA, M., R, A., A, S., V, S., . . . AW, S. (2025). Role of high-dose interleukin-2 for melanoma in the age of cellular therapy. Journal for immunotherapy of cancer, 13(5), . https://doi.org/10.1136/jitc-2024-011119

Chicago Style (17th ed.) Citation

E, Buchbinder, et al. "Role of High-dose Interleukin-2 for Melanoma in the Age of Cellular Therapy." Journal for Immunotherapy of Cancer 13, no. 5 (2025). https://doi.org/10.1136/jitc-2024-011119.

MLA (9th ed.) Citation

E, Buchbinder, et al. "Role of High-dose Interleukin-2 for Melanoma in the Age of Cellular Therapy." Journal for Immunotherapy of Cancer, vol. 13, no. 5, 2025, https://doi.org/10.1136/jitc-2024-011119.